Epinephrine-induced Insulin Resistance in Man
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 4 of the 19 sources its claims cite were checked for support.
Abstract
Endogenous release of epinephrine after stress as well as exogenous epinephrine infusion are known to result in impaired glucose tolerance. Previous studies of man and animals have demonstrated that this effect of epinephrine results from inhibition of insulin secretion and augmentation of hepatic glucose production. However, the effect of epinephrine on tissue sensitivity to insulin, and the relative contributions of peripheral vs. hepatic resistance to impaired insulin action, have not been defined. Nine young normal-weight subjects were studied with the insulin clamp technique. Plasma insulin was raised by approximately 100 muU/ml while plasma glucose concentration was maintained at basal levels by a variable glucose infusion. Under these conditions of euglycemia, the amount of glucose metabolized equals the glucose infusion rate and is a measure of tissue sensitivity to insulin. Subjects received four studies: (a) insulin (42.6 mU/m(2).min), (b) insulin plus epinephrine (0.05 mug/kg.min), (c) insulin plus epinephrine plus propranolol (1.43 mug/kg.min), and (d) insulin plus propranolol. During insulin administration alone, glucose metabolism averaged 5.49+/-0.58 mg/kg.min. When epinephrine was infused with insulin, glucose metabolism fell by 41% to 3.26 mg/kg.min (P < 0.001). After insulin alone, hepatic glucose production declined by 92% to 0.16+/-0.08 mg/kg.min. Addition of epinephrine was associated with a delayed and incomplete suppression of glucose production (P < 0.01) despite plasma insulin levels >100 muU/ml. When propranolol was administered with epinephrine, total glucose metabolism was restored to control values and hepatic glucose production suppressed normally. Propranolol alone had no effect on insulin-mediated glucose metabolism. These results indicate that epinephrine, acting primarily through a beta-adrenergic receptor, markedly impairs tissue sensitivity to an increase in plasma insulin levels, and that this effect results from both peripheral and hepatic resistance to the action of insulin.
Overview
CoChat Summary
TL;DR
In nine healthy young adults, epinephrine infusion during euglycemic hyperinsulinemia reduced insulin-mediated glucose metabolism by 41% and blunted insulin suppression of hepatic glucose production. Propranolol reversed both effects, indicating that epinephrine-induced insulin resistance is mediated primarily through β-adrenergic receptors and involves peripheral and hepatic tissues.
Key findings
- During insulin clamp alone, total glucose metabolism averaged 5.49±0.58 mg/kg·min; adding epinephrine (0.05 μg/kg·min) reduced it by 41% to 3.26±0.24 mg/kg·min (P < 0.001).
- Insulin alone suppressed endogenous glucose production by 92% to 0.16±0.08 mg/kg·min; epinephrine caused delayed and incomplete suppression (60–120 min: 0.73±0.18 vs. 0.16±0.08 mg/kg·min; P < 0.005), and during the first 20 min hepatic glucose production rose to 2.58±0.32 vs. 0.49±0.16 mg/kg·min.
- Propranolol with epinephrine restored total glucose metabolism to 5.73±0.67 mg/kg·min, not significantly different from control, and blocked epinephrine’s hepatic effect; propranolol alone had no significant effect (5.28±0.42 mg/kg·min).
- Epinephrine also potentiated the insulin-induced decline in all plasma amino acids except alanine by ~15–20% greater than insulin alone; propranolol reversed this effect.
Methods
- Design: euglycemic insulin clamp with [3-3H]glucose in nine healthy volunteers (five females, four males; age 23–30 yr, mean 26±1 yr; 90–112% ideal body weight, mean 99±2%), each serving as their own control, studied postabsorptive after a 12-h overnight fast.
- Four protocols: insulin alone (42.6 mU/m²·min), insulin plus epinephrine (0.05 μg/kg·min), insulin plus epinephrine plus propranolol, and insulin plus propranolol; plasma glucose was maintained at basal levels while plasma insulin was raised to steady-state ~132–135 μU/ml.
- Analysis: under steady-state euglycemia, glucose infusion rate equals tissue sensitivity to insulin; endogenous glucose production was calculated using tritiated glucose; data are mean±SEM with paired Student’s t tests.
Limitations
- Stated: smaller epinephrine doses, as might be expected in mild to moderate stress, were not examined; no α-adrenergic blocker was administered, so a contribution of α-adrenergic receptors to insulin antagonism cannot be excluded.
- Evident from the text: the sample was small (n=9), young, healthy, and normal-weight, and the clamp period was 2 h; propranolol co-infusion raised plasma epinephrine to 1,441±96 vs. 736±23 pg/ml with epinephrine alone, though the authors state this does not alter interpretation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 1 Not valid · 4 Not checked · 28 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“an in vivo effect of epinephrine on peripheral glucose metabolism independent of changes in plasma insulin levels has not been conclusively documnented.”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Disputedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
The Discussion reports that epinephrine reduced glucose clearance in conscious dogs despite a two- to fourfold rise in plasma insulin, and concludes that the effect was not mediated primarily by suppressed insulin secretion. This is contrary to the claim that an in vivo peripheral effect had not been documented independently of changes in insulin levels, although the paper does not claim to have excluded every contribution from insulin secretion. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several studies have documented that epinephrine inhibits insulin secretion (1–5)”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Partly supportedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
On p. 120, the paper says epinephrine subsequently inhibits insulin release in dogs. It also reports an initial twofold rise in plasma insulin and describes the effect as biphasic, so the unqualified claim omits an important timing qualification. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [3] 3. Altszuler, N., R. Steele, I. Rathgeb, and R. C. DeBodo. 1967. Glucose metabolism and plasma insulin levels during epinephrine infusion in the dog. Am. J. Physiol. 212(3): 677–682. source
- Supportedcites [4] 4. Coore, H. G., and P. J. Randle. 1964. Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. Biochem. J. 93: 66–78. source
The Results report that adrenaline (epinephrine) abolished the stimulation of insulin release by high glucose in rabbit pancreas pieces incubated in vitro. The Discussion identifies this inhibitory effect as a major finding. The paper also notes that adrenaline had no effect at low glucose; the citing sentence does not claim inhibition under every condition. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [5] 5. Porte, D. 1967. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. Clin. Invest. 46: 86–94. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During both clamp studies in which propranolol was infused, the decline in plasma glucagon was similar to the control insulin clamp study (P < 0.05).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After insulin alone, hepatic glucose production declined by 92% to 0.16±0.08 mg/kg·min.”
plainstates a causen = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During insulin administration alone, glucose metabolism averaged 5.49±0.58 mg/kg·min.”
plainn = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 35 claims and every source verdict.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased sympathovagal balance also adds to insulin resistance131”
From Interacting epidemics? Sleep curtailment, insulin resistance, and obesity (2012) · cites this paper as [131]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1210/jcem-50-2-294 · retracted 1980-11-01 · notice 10.1210/jcem-51-5-1201 · this paper published 1980-03-01
Citations
Cites
1 retracted
Soman, V., Shamoon, H., Sherwin, R. S., & Ziegler, W. H. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-294 · Cited by 22
RetractedGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRegulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro
Coore, H., & Randle, P. (1964) · Biochemical Journal · doi:10.1042/bj0930066 · Cited by 540
EFFECT OF EPINEPHRINE ON RAT DIAPHRAGM
Walaas, O., & Walaas, E. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56223-2 · Cited by 410
A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*
Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105514 · Cited by 398
Exton, J. H., Robison, G. A., Sutherland, E. W., & Park, C. R. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61771-5 · Cited by 320
DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296
Self-citationChristensen, N. J. (1974) · Diabetes · doi:10.2337/diab.23.1.1 · Cited by 287
Mechanism of Plasma Catecholamine Increases During Surgical Stress in Man
HALTER, J. B., PFLUG, A. E., & PORTE, D. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-936 · Cited by 279
Control of Gluconeogenesis in Liver
Exton, J. H., & Park, C. R. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93242-4 · Cited by 278
Cited by
Items 401–500 of 556
Elevated heart rate predicts β cell function in non-diabetic individuals: the RISC cohort
Bonnet, F., Empana, J. P., Natali, A., Monti, L. D., Golay, A., Lalic, K. S., Dekker, J., Mari, A., Balkau, B., & _, _. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0115 · Cited by 8
de Kreutzenberg, S. V., RICCIO, A., Dorella, M., Avogaro, A., Marescotti, M. C., Tiengo, A., & Prato, S. D. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01714.x · Cited by 7
Matsui, H., Hashimoto, H., Fukushima, A., Kanayama, H., Mitani, S., Toki, Y., Okumura, K., & Ito, T. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90046-0 · Cited by 7
Synthesis, Storage, and Secretion of Adrenal Medullary Hormones: Physiology and Pathophysiology
Young, J. B., & Landsberg, L. (2001) · Wiley eBooks · doi:10.1002/cphy.cp070401 · Cited by 10
Physiological insulin action is opposed by beta-adrenergic mechanisms in dogs
Werther, G. A., Joffe, S. N., Artal, R., & Sperling, M. A. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.1.e33 · Cited by 9
Mohammed, I. I., Adamu, I. I., & Barka, S. J. (2019) · Modeling and Numerical Simulation of Material Science · doi:10.4236/mnsms.2019.94005 · Cited by 6
“When epinephrine is secreted into the blood stream, the insulin secretion by pancreatic β-cells will be suppressed by 41% [5].”
BackgroundSalahdeen, H. M., & Alada, A. R. A. (2009) · Nigerian Journal of Physiological Sciences · doi:10.4314/njps.v24i1.46378 · Cited by 6
Hypertension and Hyperinsulinemia
Kaplan, N. M. (1991) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(21)00341-9 · Cited by 7
Insulin resistance, hypertension and cellular ion transport systems
Solini, A., & DeFronzo, R. A. (1992) · Acta Diabetologica · doi:10.1007/bf00573488 · Cited by 6
“SNS activation is also a potent antagonist of insulin action [26], causing insulin resistance and hyperinsulinaemia.”
BackgroundSelf-citationMeans, L. W., & Edmonds, S. M. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050120 · Cited by 6
“The released epinephrine then stimulates phosphorylase in the liver to release glucose into the blood (Deibert and DeFronzo, 1980; Wenk, 1989).”
BackgroundCoffee and Type 2 Diabetes Risk
Matusheski, N. V., Bidel, S., & Tuomilehto, J. O. (2012) · Wiley eBooks · doi:10.1002/9781119949893.ch8 · Cited by 8
Insulin effect in chronic alcoholics during alcohol withdrawal
Adner, N., & Nygren, A. (1982) · Diabetologia · doi:10.1007/bf00283756 · Cited by 6
“Previous studies indicate that the combined infusion of insulin, glucose, propranolol and adrenaline inhibit hepatic glucose output [ 1 , 8, 9]. However, these studies were done on healthy subjects with normal liver function.”
BackgroundFischer, A., Remde, H., Pamporaki, C., Dischinger, U., Bechmann, N., Robledo, M., Wang, K., Vetter, D., Oberholzer, J., Morand, G. B., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae901 · Cited by 10
Martinot, J., Lê-Dông, N.-N., Borel, A., Tamisier, R., Malhotra, A., & Pépin, J. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15169 · Cited by 6
“These large intrathoracic pressure swings activate the sympathetic nervous system and, in turn, there is compelling mechanistic evidence that sympathetic activation negatively affects insulin secretion and sensitivity.(34,35) Overall, there appears to be a role for a tool that can objectively measure sleep time spent…”
BackgroundThe Adrenergic System in Cardiovascular Metabolism and Aging
Santulli, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-13680-6_6 · Cited by 7
Variability of insulin sensitivity during the first 4 days of critical illness
Pretty, C. G., Compte, A. L., Chase, J. G., Shaw, G. M., Preiser, J.-C., Penning, S., & Desaive, T. (2012) · Critical Care · doi:10.1186/cc10774 · Cited by 5
Relation between resting heart rate and the risk of ventricular tachyarrhythmias in MADIT-RIT
Beinart, R., Kutyifa, V., McNitt, S. A., Huang, D. T.-C., Aktaş, M. K., Rosero, S. Z., Goldenberg, I., & Nof, E. (2020) · EP Europace · doi:10.1093/europace/euz353 · Cited by 6
Feingold, K. R. (2015) · Europe PMC (PubMed Central) · Cited by 7
Lugli, A. K., Donatelli, F., Schricker, T., Kindler, C. H., Wykes, L., & Carli, F. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003126 · Cited by 7
“decreased secretion and peripheral action of insulin((2)).”
Aksnes, T. A., Flaa, A., Sevre, K., Mundal, H. H., Rostrup, M., & Kjeldsen, S. E. (2008) · Blood Pressure · doi:10.1080/08037050802162847 · Cited by 5
“Enhanced sympathetic tone may cause peripheral insulin resistance by b-adrenergic receptor stimulation (16), by conversion to more fast-twitch insulin-resistant muscle fibres (17), by decreased capillary density (18) and/or by a-adrenergic vasoconstriction (19–22).”
Backgroundβ-Adrenergic regulation of glucose disposal: A reciprocal relationship with insulin release
Bessey, P. Q., & Wilmore, D. W. (1983) · Journal of Surgical Research · doi:10.1016/0022-4804(83)90089-6 · Cited by 5
Ørskov, L., Schmitz, O., Bak, J. F., Lund, S. A., Kaal, A., Nyholm, B., & Møller, N. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655101316911413 · Cited by 7
SYMPATHETIC OVERACTIVITY AND CORONARY RISK IN HYPERTENSION
Amerena, J. V., & Julius, S. (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00882.x · Cited by 5
“Infusion of epinephrine causes an acute /3-receptormediated insulin resistance.(55) This acute resistance of skeletal muscles to the effects of insulin, together with an actual suppression of insulin secretion,(109) leads to an increase of blood glucose during epinephrine infusion.”
BackgroundAlterations in plasma amino acid levels in children with asthma: A preliminary investigation
Inselman, L. S., Khan, F., & Evans, H. E. (1986) · Pediatric Pulmonology · doi:10.1002/ppul.1950020309 · Cited by 5
Endocrine Disorders that Cause Diabetes
Jennings, R. E., & Hanley, N. A. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch20 · Cited by 5
Carranza, M. C., Simón, M. A., Torres, A., et al. (1990) · Bioscience Reports · doi:10.1007/bf01116579 · Cited by 5
Oshida, Y., OHSAWA, I., Sato, J., & Sato, Y. (1993) · Endocrine Journal · doi:10.1507/endocrj.40.99 · Cited by 6
Epinephrine inhibits PI3Kα via the Hippo kinases
Lin, T.-Y., Ramsamooj, S., Perrier, T., Liberatore, K. M., Lantier, L., Vasan, N., Karukurichi, K. R., Hwang, S., Kesicki, E. A., Kastenhuber, E. R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113535 · Cited by 4
“Epi is known to reduce glucose uptake into these tissues in both rodents and humans 9,59 PI3K inhibition likely plays an important role in this effect.”
BackgroundNormoglycemia in Nondiabetic African Americans Hospitalized With Heart Failure
Shook, M. S., Zafarullah, H., Nelson, M. D., Bhattacharya, S. K., Davis, R. C., Newman, K. P., & Weber, K. T. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181b272c7 · Cited by 4
Yano, Y., Haimoto, H., Hoshide, S., Kabutoya, T., Eguchi, K., & Kario, K. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.46 · Cited by 4
Desoyé, G., Ertl-Stockinger, U., & Porta, S. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90340-h · Cited by 4
Endocrine Regulation of Neonatal Hypoxia: Role of Glucose, Oxygen, and Epinephrine Supplementation
Anju, T. R., Nandhu, M. S., P, J. J., & Cs, P. (2011) · Fetal and Pediatric Pathology · doi:10.3109/15513815.2011.587498 · Cited by 5
“Epinephrine is known to inhibit insulin secretion [27] but will also cause hyperglycemia, which can secondarily increase insulin secretion [28].”
BackgroundHypertension and Insulin Resistance
Natali, A., Taddei, S., & Ferrannini, E. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-3906-0_16 · Cited by 4
Metabolic antagonism between insulin action and activators of adenylate cyclase in rat fat cells
Page-Peñuelas, A., Jimenez, J. J., & Moreno, F. J. (1987) · International Journal of Biochemistry · doi:10.1016/0020-711x(87)90317-x · Cited by 4
Insulin Modifies the Glucose Response to Mental Stress Independently of Forearm Blood Flow
HØIEGGEN, E. F. A. (1998) · Blood Pressure · doi:10.1080/080370598437150 · Cited by 4
Diseases of New World Camelids
Dowd, O., & Catherine, M. (2014) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 8
Endocrinological and behavioural adaptations to experimentally induced physical stress in horses
de Graaf‐Roelfsema, E. (2007) · Utrecht University Repository (Utrecht University) · Cited by 7
Overview of Glucose Metabolism
Holt, R. I. G. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch6 · Cited by 6
Agustín, R. M., Pino, A. C.-D., Sanz, A. J. L., Palanca, A., Rossetti, P., Romero, C. M., Bondía, J., & Ampudia‐Blasco, F. J. (2025) · Sports Health A Multidisciplinary Approach · doi:10.1177/19417381251316247 · Cited by 3
“8,20 Regarding the long-term effects of both exercises on glucose homeostasis, we observed an improvement in TIR up to 24 hours after exercise compared with the 24 hours before exercise, both with CONT (48.9% before, 59.3% after) and with EB-HIIE (50.0% before, 66.5% after).”
InfluentialDiabetes from Catecholamine Excess
Mannelli, M., Parenti, G., Zampetti, B., Canu, L., & Mannucci, E. (2014) · Frontiers in diabetes · doi:10.1159/000357245 · Cited by 3
Hu, J., Teng, C.-G., Chu, G.-P., Han, D., Fu, H., Zhou, Y., Wang, Q., Wang, B., Shen, H., Liu, F., et al. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2018.1451537 · Cited by 3
“Meanwhile, an increasing number of studies have supported the central role of the sympathetic nervous system in the pathophysiology of hypertension (29,30), so increased RHR leads to elevated blood pressure via the following several pathways: first, a sympathetic overactivation increases the vasoconstriction of resist…”
BackgroundSympathetic nervous system and metabolism
Carlson, G., & Little, R. (1999) · Springer eBooks · doi:10.1007/978-88-470-2901-9_6 · Cited by 3
Diabetes Mellitus as a Primary Manifestation of Multiple Endocrine Neoplasia Type 2B
Donckier, J. E., Rosière, A., Heureux, F., & Michel, L. A. (2008) · Acta chirurgica Belgica · doi:10.1080/00015458.2008.11680325 · Cited by 3
“Finally, adrenaline limits glucose utilization in muscle through direct b2-adrenergic effects (17).”
BackgroundPapanikolaou, J., Makris, D. A., & Zakynthinos, E. G. (2014) · Critical Care · doi:10.1186/s13054-014-0490-4 · Cited by 3
Ferrara, L. A., Capaldo, B., Rivellese, A. A., Genovese, S., Iovine, C., Mastranzo, P., Cirillo, F., & Mancini, M. (1987) · European Journal of Clinical Pharmacology · doi:10.1007/bf00637561 · Cited by 3
“infusion of propranolol prevented the effect of epinephrine on peripheral insulin sensitivity, while, when given alone, it had no effect on this parameter [14].”
BackgroundCatecholamine Excess In Pheochromocytoma Inducing Insulin Resistance
Raza, S. A., DeWitt, R. T., Chen, H., WARNER, T. F. C. S., & Blank, R. D. (2004) · Endocrine Practice · doi:10.4158/ep.10.2.149 · Cited by 3
Salahdeen, H. M., & Alada, A. R. A. (2010) · Nigerian Journal of Physiological Sciences · doi:10.4314/njps.v24i2.52897 · Cited by 3
Characteristics of Prehypertension in Black Children
Falkner, B. E. (1993) · Springer eBooks · doi:10.1007/978-1-4614-7577-4_3 · Cited by 3
A Quantitative Analysis of the Subcellular Distribution of Human Skeletal Muscle Glycogen
Marchand, I. (2002) · Canadian Journal of Applied Physiology · doi:10.1139/h02-007 · Cited by 3
Solini, A., & DeFronzo, R. A. (1996) · Springer eBooks · doi:10.1007/978-1-4757-6749-0_7 · Cited by 4
Self-citationHowe, H. L., Lehnherr, M., & Qualls, R. Y. (1995) · Cancer Causes & Control · doi:10.1007/bf00052776 · Cited by 3
Shimosawa, T., Ando, K., & Fujita, T. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)84102-1 · Cited by 3
Contrainsulin Hormones: Biochemical and Physiological Aspects
Gerich, J. E., & Cryer, P. E. (1991) · Springer eBooks · doi:10.1007/978-1-4684-0400-5_6 · Cited by 3
Monoacylglycerol as a Metabolic Coupling Factor in Glucose-Stimulated Insulin Secretion
Zhao, S., Iglesias, J., Mugabo, Y., Peyot, M., Joly, E. C., Madiraju, S. R. M., & Prentki, M. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.019 · Cited by 2
“(Deibert and DeFronzo, 1980) These catecholamines via α-adrenergic receptors reduce”
BackgroundExplorations cardiologiques nucléaires dans la cardiomyopathie de Takotsubo
Cimarelli, S., Imperiale, A., Sauer, F., et al. (2008) · Médecine Nucléaire · doi:10.1016/j.mednuc.2007.10.010 · Cited by 2
Chiba, A., Hamaguchi, M., Tatsuya, T., Asai, T., Hiroaki, O., & Chichibu, S. (1991) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(91)90490-4 · Cited by 2
Obstructive sleep apnea and glucose metabolism
Polak, J., Beamer, B. A., & Punjabi, N. M. (2011) · Informa Healthcare eBooks · doi:10.3109/9781420020885.014 · Cited by 4
Physiological Basis of Insomnia
Bonnet, M. H., & Arand, D. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-042-7_3 · Cited by 2
“For example, hypertension; elevated plasma insulin [29] and its related decrease in HDL cholesterol; increase in triglyceride and cholesterol [30]; increased hematocrit [31]; decreased plasma volume [32]; increased plasma thromboglobulin [33]; increased plasma angiotensin [34]; and increased cardiac arrhythmias [35, 3…”
BackgroundGans, R. O. B., & Donker, A. J. M. (1994) · Springer eBooks · doi:10.1007/978-1-4757-6746-9_25 · Cited by 2
Physiologische Grundlagen der Insulinsubstitution
Waldhäusl, W. K. (1990) · Springer eBooks · doi:10.1007/978-3-642-74610-9_5 · Cited by 2
Effect of stress hormones on transsplanchnic balance of exogenous amino acids in healthy man
Ratheiser, K., Komjati, M., Gasic, S., Bratusch-Marrain, P. R., & Waldhäusl, W. K. (1991) · Metabolism · doi:10.1016/0026-0495(91)90032-r · Cited by 2
Hormonal and metabolic control of hepatic carbohydrate metabolism
Jakob, A. (1981) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(81)90009-1 · Cited by 3
Systemic stress response and hyperglycemia after abdominal surgery in rat and man
Hager, P. (2008) · Figshare · Cited by 2
Carbohydrate Metabolism in Liver Disease
Soeters, P. B., de Boer, J. E. G., Oostenbroek, R. J., & Janssen, M. (1984) · Springer eBooks · doi:10.1007/978-1-4684-4787-3_15 · Cited by 3
Mechanisms of hypertension in hyperinsulinemic and insulin resistant fructose hypertensive rats
Verma, S. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0088178 · Cited by 3
Cardiac Nuclear Imaging Findings in Atypical Variants of Takotsubo Cardiomyopathy
Feo, M. S. D., Conte, M., Frantellizzi, V., et al. (2024) · Applied Sciences · doi:10.3390/app14020487 · Cited by 1
Chaieb, I. A., Kacem, F. H., Mnif, M., Turki, M., Heyman, E., Hammouda, O., Taleb, N., Abid, M., Zouari, M., RABASA-LHORET, R. P. R., et al. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.06.001 · Cited by 1
Abnormal Autonomic Nervous Control of the Cardiovascular System
Rosano, G. M. C., Fragasso, G., & Chierchia, S. L. (1999) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5181-2_21 · Cited by 1
“In addition to the effect of vasoconstriction, sympathetic stimulation can induce acute insulin resistance through B-adrenergic receptor stimulation and their blockade can reinstate a normal glucose uptake [ 48 ].”
BackgroundRajeswaran, C., Bodansky, H. J., & Orme, S. (2005) · Practical Diabetes · doi:10.1002/pdi.857 · Cited by 1
Rawal, S. R. (2013) · Cited by 1
Síndrome de apnea-hipopnea obstructiva del sueño (SAHOS) y embarazo
Bourjeily, G. R., Palacio, N. L., & Rojas-Suárez, J. A. (2017) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v65n1sup.59525 · Cited by 5
“El aumento de la actividad simpática puede inhibir la secreción pancreática de insulina, empeorando su resistencia (56-59).”
BackgroundDiabetic ketoacidosis after the treatment of anaphylaxis
Brenner, D., Kleinman, K., Manzo, A., et al. (2022) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-21-0171 · Cited by 1
Therapeutic potential of GLP-1RAs in sleep apnea with genetic associations to type 2 diabetes
Cheng, F., Yang, K., Wang, Y., Yang, F., Niu, X., & Li, W. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01699-4 · Cited by 1
“Previous research by Strausz et al. [44] has high-lighted a significant genetic correlation (rg = 0.52, p = 6.4010 − 12 ) between OSA and T2D, indicating a possible shared genetic foundation for both conditions.”
InfluentialButler, P. W., Légaré, J., & White, C. W. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i10.111212 · Cited by 1
Gil, J. D. S. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-25022015-083517 · Cited by 2
Type I Diabetes Mellitus (Insulin‐Dependent Diabetes Mellitus)
Rizza, R. A., Jensen, M. D., & Nair, K. S. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070236 · Cited by 4
Importance of Heart Rate in Determining Cardiovascular Risk
Palatini, P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-978-3_8 · Cited by 2
“This association was found in the Norwegian Timolol Multicenter Study ( 19 ) and in a study by Hjalmarson et al. (20) in which the total mortality was 14% in the subjects with an admission heart rate less than 60 bpm, 41% in the subjects with a heart rate greater than 90 bpm, and 48% in those with a heart rate greater…”
BackgroundMancini, A., Valle, D., Conte, G., Perrelli, M., Menini, E., Mignani, V., Carducci, P., Corte, F. D., & Marinis, L. D. (1996) · Springer eBooks · doi:10.1007/978-1-4612-2396-2_21 · Cited by 1
Insulin regulation of muscle glucose metabolism: Role of pre‐receptorial mechanisms
Capaldo, B., & Saccà, L. (1995) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610110405 · Cited by 1
Nordby, G., Moan, A., Kjeldsen, S. E., Eide, I. K., & Os, I. (1995) · Blood Pressure · doi:10.3109/08037059509077609 · Cited by 1
The effect of physical exercise and resting heart rate on cardiovascular risk
Bemelmans, R. H. H. (2012) · Utrecht University Repository (Utrecht University) · Cited by 1
Mitochondrial complex I protein is related to residual feed intake in beef cattle
Ramos, M. H. (2011) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/14444 · Cited by 1
“34 insulin secretion by the pancreas (Deibert and Defronzo, 1980).”
Hosoda, R., HATTORI, M., Shimada, Y., Shimomura, H., & MATUURA, M. (1991) · THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA · doi:10.2199/jjsca.11.570 · Cited by 2
Mullins, G. R. (2015) · doi:10.18130/v3v261 · Cited by 1
Glucose Metabolism in Uremia: Effect of Hemodialysis and CAPD
MAK, R. H. K., & CHANTLER, C. (1985) · Springer eBooks · doi:10.1007/978-3-642-70213-6_8 · Cited by 1
“Elevated levels of growth hormone [27], glucagon [28, 29], glucocorticoids [12, 30], adrenaline [31], prolactin [32], and parathyroid hormone [33] are known to be antagonistic to the hypoglycemic action of insulin.”
BackgroundAntihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats
Bhanot, S., Michoulas, A., & McNeill, J. H. (1995) · Springer eBooks · doi:10.1007/978-1-4613-1251-2_27 · Cited by 1
Importance of Heart Rate in Determining Cardiovascular Risk
Palatini, P. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-004-9_7 · Cited by 1
Counterregulatory Hormones: Molecular, Biochemical, and Physiologic Aspects
Gerich, J. E., & Cryer, P. E. (1998) · Springer eBooks · doi:10.1007/978-1-4612-1642-1_9 · Cited by 1
Sind β-Adrenorezeptoren-Blocker bei Patienten mit Diabetes mellitus kontraindiziert?
Smith, U., & Lager, I. (1983) · Springer eBooks · doi:10.1007/978-3-642-69080-8_3
Gnatzy, R. (2014) · Qucosa (Saxon State and University Library Dresden)
Expression of Inflammatory and Insulin Signaling Genes in Acute and Chronic Stress
Witasp, A. (2010) · Figshare
Silva, C. C. S. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2008.tde-21012009-113620
Anju, T. R., & Paulose, C. S. (2010) · Dyuthi Digital Repository (Cochin University of Science and Technology)
The Role of Systemic Inflammation in the Development of Equine Laminitis
Tadros, E. M. (2011)
Frier, B. M., Corrall, R. J. M., O'Brien, I. A. D., Lewin, I. G., HAY, I. D., & Roland, J. (1985) · Metabolism · doi:10.1016/0026-0495(85)90076-9 · Cited by 1
Gasperi, D. D., da Silveira, E. A., da Silva, D. R. P., Pereira, R. C. D. F., Portela, L. O. C., Brass, K. E., & Côrte, F. D. D. L. (2011) · Ciência Rural · doi:10.1590/s0103-84782011000300016 · Cited by 2
Gouda, K. (1992) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.38.343
IN VIVO INSULIN SENSITIVITY IN ADRENODEMEDULLATED RATS
Yamamoto, C., Sato, Y., Oshida, Y., et al. (1990) · Folia Endocrinologica Japonica · doi:10.1507/endocrine1927.66.2_127
29. INSULIN AND BLOOD PRESSURE
Ziekenhuis, A. (1996)
Metadata
- Authors
- Deibert, D. C., & Defronzo, R. A.
- Affiliations
- Yale University (US)
- ORCID
- Defronzo, Ralph A.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-03-01
- Volume
- 65
- Issue
- 3
- Pages
- 717-721
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371414
- OpenAlex
- W2064971980
- Cited by
- 557
- References
- 21
- Citations by year
- 2026: 12 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 5 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 16 · 2014: 21 · 2013: 10 · 2012: 18
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- epinephrine, insulin resistance, beta-adrenergic receptors, propranolol, hepatic glucose production, glucose metabolism, insulin secretion, hyperinsulinemic-euglycemic clamp, peripheral insulin sensitivity, stress hyperglycemia
- MeSH terms
- Adult, Amino Acids, Blood Glucose, Drug Resistance, Epinephrine, Female, Glucagon, Glucose, Humans, Insulin, Liver, Male, Propranolol, Receptors, Adrenergic, beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.